4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride

C128H181Cl3F25N17O38S7 — CID 162102918

About 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride

4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride (PubChem CID 162102918) has the molecular formula C128H181Cl3F25N17O38S7 and a molecular weight of 3371.71 g/mol. Its IUPAC name is 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride.

Molecular Properties

• Compound Name: 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride
• PubChem CID: 162102918
• Molecular Formula: C128H181Cl3F25N17O38S7
• Molecular Weight: 3371.71 g/mol
• Exact Mass: 3367.95
• IUPAC Name: 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride
• SMILES: CCC=C1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCc1ccc(C2CCN(S(=O)(=O)C3(C(=O)NO)CCOCC3)CC2)nc1.Cl.Cl.Cl.O=C(NO)C1(S(=O)(=O)N2CCC(COCC(F)(F)C(F)(F)C(F)(F)C(F)F)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(CCC(F)(F)C(F)(F)F)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(CCC(F)(F)F)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OC(F)(F)C(F)(F)F)cc3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OC(F)(F)C(F)F)cc3)CC2)CCOCC1
• InChI: InChI=1S/C20H26F5N3O5S.C20H31N3O5S.C19H23F5N2O6S.C19H24F4N2O6S.C19H26F3N3O5S.C17H24F8N2O6S.C14H24N2O5S.3ClH/c21-19(22,20(23,24)25)6-3-14-1-2-16(26-13-14)15-4-9-28(10-5-15)34(31,32)18(17(29)27-30)7-11-33-12-8-18;1-2-3-4-16-5-6-18(21-15-16)17-7-11-23(12-8-17)29(26,27)20(19(24)22-25)9-13-28-14-10-20;20-18(21,22)19(23,24)32-15-3-1-13(2-4-15)14-5-9-26(10-6-14)33(29,30)17(16(27)25-28)7-11-31-12-8-17;20-16(21)19(22,23)31-15-3-1-13(2-4-15)14-5-9-25(10-6-14)32(28,29)18(17(26)24-27)7-11-30-12-8-18;20-19(21,22)6-3-14-1-2-16(23-13-14)15-4-9-25(10-5-15)31(28,29)18(17(26)24-27)7-11-30-12-8-18;18-12(19)16(22,23)17(24,25)15(20,21)10-33-9-11-1-5-27(6-2-11)34(30,31)14(13(28)26-29)3-7-32-8-4-14;1-2-3-12-4-8-16(9-5-12)22(19,20)14(13(17)15-18)6-10-21-11-7-14;;;/h1-2,13,15,30H,3-12H2,(H,27,29);5-6,15,17,25H,2-4,7-14H2,1H3,(H,22,24);1-4,14,28H,5-12H2,(H,25,27);1-4,14,16,27H,5-12H2,(H,24,26);1-2,13,15,27H,3-12H2,(H,24,26);11-12,29H,1-10H2,(H,26,28);3,18H,2,4-11H2,1H3,(H,15,17);3*1H
• InChIKey: DCDXTZKZTNTHHK-UHFFFAOYSA-N
• XLogP: 16.51
• TPSA: 737.94 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 41
• Rotatable Bonds: 47
• Heavy Atoms: 218
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3371.71
LogP ≤ 5	16.51
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	41

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Perfluorinated_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride?

The IUPAC name of 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride (CID 162102918) is 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride.

What is the SMILES notation for 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride?

The canonical SMILES for 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride is CCC=C1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCc1ccc(C2CCN(S(=O)(=O)C3(C(=O)NO)CCOCC3)CC2)nc1.Cl.Cl.Cl.O=C(NO)C1(S(=O)(=O)N2CCC(COCC(F)(F)C(F)(F)C(F)(F)C(F)F)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(CCC(F)(F)C(F)(F)F)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(CCC(F)(F)F)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OC(F)(F)C(F)(F)F)cc3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OC(F)(F)C(F)F)cc3)CC2)CCOCC1.

What is the InChIKey of 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride?

The InChIKey is DCDXTZKZTNTHHK-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H26F5N3O5S.C20H31N3O5S.C19H23F5N2O6S.C19H24F4N2O6S.C19H26F3N3O5S.C17H24F8N2O6S.C14H24N2O5S.3ClH/c21-19(22,20(23,24)25)6-3-14-1-2-16(26-13-14)15-4-9-28(10-5-15)34(31,32)18(17(29)27-30)7-11-33-12-8-18;1-2-3-4-16-5-6-18(21-15-16)17-7-11-23(12-8-17)29(26,27)20(19(24)22-25)9-13-28-14-10-20;20-18(21,22)19(23,24)32-15-3-1-13(2-4-15)14-5-9-26(10-6-14)33(29,30)17(16(27)25-28)7-11-31-12-8-17;20-16(21)19(22,23)31-15-3-1-13(2-4-15)14-5-9-25(10-6-14)32(28,29)18(17(26)24-27)7-11-30-12-8-18;20-19(21,22)6-3-14-1-2-16(23-13-14)15-4-9-25(10-5-15)31(28,29)18(17(26)24-27)7-11-30-12-8-18;18-12(19)16(22,23)17(24,25)15(20,21)10-33-9-11-1-5-27(6-2-11)34(30,31)14(13(28)26-29)3-7-32-8-4-14;1-2-3-12-4-8-16(9-5-12)22(19,20)14(13(17)15-18)6-10-21-11-7-14;;;/h1-2,13,15,30H,3-12H2,(H,27,29);5-6,15,17,25H,2-4,7-14H2,1H3,(H,22,24);1-4,14,28H,5-12H2,(H,25,27);1-4,14,16,27H,5-12H2,(H,24,26);1-2,13,15,27H,3-12H2,(H,24,26);11-12,29H,1-10H2,(H,26,28);3,18H,2,4-11H2,1H3,(H,15,17);3*1H.

What are the key properties of 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride?

4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride has a molecular weight of 3371.71 g/mol, XLogP of 16.51, 47 rotatable bonds, 14 hydrogen bond donors, and 41 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[4-(5-butyl-2-pyridinyl)piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-(2,2,3,3,4,4,5,5-octafluoropentoxymethyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,4,4,4-pentafluorobutyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-(4-propylidenepiperidin-1-yl)sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(3,3,3-trifluoropropyl)-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;trihydrochloride is sourced from PubChem (CID 162102918), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).